Bensen Daniel 4
4 · Tyra Biosciences, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Bensen Daniel
Chief Discovery Officer
Transactions
- Sale
Common Stock
2024-03-01$20.04/sh−2,900$58,112→ 439,936 total - Sale
Common Stock
2024-03-04$20.08/sh−5,063$101,654→ 434,873 total - Sale
Common Stock
2024-03-05$20.02/sh−1,189$23,802→ 433,684 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.10. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.